Accepted: 17 May 2019
First Online: 17 June 2019
: C.C. is a named inventor on several patents pertaining to cavitation nucleation, mapping, monitoring and control, and a founder, director, shareholder and consultant receiving consultancy income from OxSonics Ltd, a spin-out from the University of Oxford developing a commercial product to enable the clinical translation of cavitation-mediated drug delivery. E.S. is a named inventor on two patents relating to the use of microbubbles for therapeutic applications and a founder of SonoTarg Ltd, a spin-out company developing oxygen-loaded microbubbles for cancer treatment.